Outcomes of Pregnancy in COVID-19-Positive Mothers in a Tertiary Centre

• Published in: Life (Basel, Switzerland) Switzerland), 2023-06, Vol.13 (7), p.1491
• Main Authors: Subramaniam, Vigneshwaran, Ng, Beng Kwang, Phon, Su Ee, Muhammad Rafi'uddin, Hamizan, Wira Sorfan, Abd Razak, Siti Hajar, Abd Azman, Nor Azlin, Mohamed Ismail
• Format: Article
• Language: English
• Subjects: Birth weight; Childbirth & labor; Coronaviruses; COVID-19; Data analysis; Health aspects; Health risks; infection; maternal; Mothers; Neonates; Pandemics; Patient outcomes; perinatal; Population studies; Pregnancy; Pregnancy, Complications of; Premature birth; Risk; Risk factors; Statistical analysis; Vaccination; Viral diseases; Womens health
• ISSN: 2075-1729; 2075-1729
• DOI: 10.3390/life13071491

COVID-19 is an emerging global pandemic with potential adverse effects during pregnancy. This study aimed to determine the adverse maternal and foetal outcomes due to COVID-19 infection. We also compared maternal and neonatal outcomes with regard to the timing of diagnosis (first and second trimester vs. third and fourth trimester); early COVID-19 (stage I and II) vs. severe-stage COVID-19 (III, IV, and V); and lastly, women who were partially vaccinated vs. unvaccinated. This was a retrospective study conducted in HCTM from January 2021 to January 2022. All pregnant women admitted for COVID-19 infections were recruited. The patients' records were traced. Adverse maternal and neonatal outcomes were documented and analysed. There were 172 pregnant women recruited into this study. We excluded twenty-four patients with incomplete data and nine women who delivered elsewhere. The final 139 patients were available for data analysis. The majority of women were in their third trimester of pregnancy (87.8%); however, only 5.0% and 7.2% were in the first and second trimesters, respectively. The study population had a median BMI of 29.1 kg/m and almost half of them had never received a COVID-19 vaccination. A sub-analysis of data concerning adverse maternal and foetal outcomes comparing early vs. severe stages of COVID-19 infection showed that severe-stage disease increased the risk of preterm birth (54.5% vs. 15.4%, < 0.001) and preterm birth before 34 weeks (31.9% vs. 2.6%, < 0.001) significantly. The severe-stage disease also increased NICU admission (40.9% vs. 15.4%, = 0.017) with lower birth weight (2995 g vs. 2770 g, = 0.017). The unvaccinated mothers had an increased risk of preterm birth before 34 weeks and this was statistically significant (11.6% vs. 2.9%, = 0.048). Adverse pregnancy outcomes such as ICU admission or patient death could occur; however, the clinical course of COVID-19 in most women was not severe and the infection did not significantly influence the pregnancy. The risk of preterm birth before 34 weeks was higher in a more severe-stage disease and unvaccinated mother. The findings from this study can guide and enhance antenatal counselling of women with COVID-19 infection, although they should be interpreted with caution in view of the very small number of included cases of patients in the first and second trimesters.